While not technically new, we have more information on the massive $7.3bn round for Didi Chuxing that we talked about on last Monday’s podcast. Poly Group, a Chinese state-owned real estate and trading business, contributed a whopping $400m in return for a 1.45% stake.
HR Bio Holdings, a joint venture between pharmaceutical company Jiangsu Hengrui Medicine and an unnamed blue chip investment firm, injected $100m to launch a US-based cancer therapy startup named Hengrui Therapeutics.
Xinmei Mutual Insurance Association attracted $150m from a consortium featuring Ant Financial.
Johns Hopkins spinout Blade Therapeutics raises $45m in its series B round.
University and Government
University College Dublin and Trinity College Dublin have set up a $68m fund in partnership with Atlantic Bridge that was also backed by the European Investment Fund and Enterprise Ireland, the development agency of the Irish government, as well as banks AIB and Bank of Ireland.
Kellogg – yes, the makers of the breakfast cereals – is venturing into the CVC sphere with a $100m unit that will seek out opportunities in the food industry.
Shenzhen Hepalink, a Chinese pharmaceutical firm, invested $60m in the latest fund raised by TPG Biotech. The commitment follows the company’s decision to back the previous fund 18 months ago with $22m. TPG Biotech has invested in more than 50 companies since 2002.
Twilio, a business communication platform that was actually expected to delay its flotation and wait out the UK referendum results, but ended up not doing that. Instead, it upsized its IPO, raising $150m.
Selecta Biosciences, a synthetic vaccine particle developer, also got in on the IPO game ahead of the referendum, pricing its flotation at $70m and providing an exit to Sanofi-Genzyme Bioventures.
EDFI, the Association of European Development Finance Institutions, has appointed two new people.
Dartmouth College meanwhile is losing two staff members, Tillmann Gerngross and Trip Davis – the two who helped establish the university’s tech transfer office, the Office of Entrepreneurship and Technology Transfer, in 2013.
Softbank’s COO and president Nikesh Arora has left.
Lockheed Martin Ventures, the newly established CVC unit of the aerospace and security company, has brought Christoper Moran on board as executive director and general manager.